Lipids and lipoproteins in persons with Down's syndrome.
Adults with Down syndrome carry worse lipids yet sometimes escape heart attacks, so screen early and hunt for other protectors.
01Research in Context
What this study did
Researchers compared blood fats in adults with Down syndrome to adults without it. They wanted to see if good fats protected people with Down syndrome from heart disease.
They drew blood and measured triglycerides, HDL, and other lipids in both groups.
What they found
The Down syndrome group had higher triglycerides and lower HDL. These are the same bad numbers usually linked to more heart trouble.
The results did not support the idea that good lipids shield people with Down syndrome from coronary disease.
How this fits with other research
Gastelum Guerrero et al. (2024) later pooled 15 studies and confirmed the 1992 pattern. Their meta-analysis of 1,569 people now supersedes the small early report with firmer numbers.
Stancliffe et al. (2007) followed adults with Down syndrome over time and found higher midlife cardiac deaths. This extends the lipid finding into real-world risk.
Tenenbaum et al. (2012) showed the same group lands in hospital more often for cardiac and breathing problems, again linking the bad lipid picture to clinical events.
Why it matters
If you support adults with Down syndrome, do not assume they are heart-safe. Schedule lipid panels early and repeat them. Pair results with thyroid and weight checks, then refer when triglycerides or HDL drift. Your prompt action can cut later hospital stays and cardiac deaths.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add lipid review to the annual health checklist for every adult client with Down syndrome.
02At a glance
03Original abstract
This study was designed to investigate whether the observed decreased prevalence of coronary artery disease in individuals with Down's syndrome may be explained by their serum lipid and lipoprotein profiles. Twenty-seven persons with Down's syndrome and 23 non-affected control individuals were enrolled in this study. Their fasting venous blood was analysed for total cholesterol, triglyceride, LDH cholesterol, HDL cholesterol, apo B and apo AI. The results revealed no significant differences between the study and control group with regard to total cholesterol, LDL cholesterol, apo B and the apo B:apo AI ratio. However, triglyceride levels were significantly increased, and serum HDL cholesterol, apo AI and HDL cholesterol:total cholesterol ratio were significantly decreased in patients with Down's syndrome when compared with the control group. The latter observations are all associated with an increased risk for coronary artery disease. Therefore, it is concluded that the decreased prevalence of coronary artery disease in individuals with Down's syndrome cannot be explained by the lipid and lipoprotein levels observed in this study population.
Journal of intellectual disability research : JIDR, 1992 · doi:10.1111/j.1365-2788.1992.tb00535.x